Osteoporosis: Measuring the Problem

Slides:



Advertisements
Similar presentations
Osteoporosis 9 th January 2013 Dr Julian Tomkinson.
Advertisements

OSTEOPOROSIS An overview of the condition and its treatment
1 International Osteoporosis Foundation & European Society of Musculoskeletal Radiology VERTEBRAL FRACTURE INITIATIVE Slide Kit Part 1: Osteoporosis and.
Osteoporosis Dr. Aisha Sheikh FCPS (Pak), Fellowship Diabetes/Endocrinology (AKUH), PG Dip Diab (UK) Consultant Endocrinologist.
A progressive bone disease characterized by decrease bone mass decreased bone density increased fracture risk Dr Gaurav Rathore MS Ortho, MCh Ortho, FRCS.
Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.
Osteoporosis – newer treatments Dr A K Bhalla ConsultantRheumatologist Royal National Hospital for Rheumatic Diseases, Bath.
Osteoporosis Wang Ying Department of Rehabilitation Medicine Renji Hospital, Jiaotong University.
WHO Osteoporosis Definition (1996)
Falls and Fracture in the Elderly Tuan V. Nguyen Bone and Mineral Research Program Garvan Institute of Medical Research.
Vietnam Osteoporosis Workshop, HCMC 2006 RISK FACTORS FOR OSTEOPOROTIC FRACTURE IN THE ELDERLY Tuan Van Nguyen and Nguyen Dinh Nguyen Garvan Institute.
King Abdul Aziz University Faculty Of Pharmacy
Nahid Rianon, M.D., Dr.P.H. The University of Texas Health Science Center at Houston Osteoporosis Educational Series, Lecture 1of 3: A Public Health Problem.
Dr santosh kumar Assistant professor Medical unit 2.
Osteoporosis UBC Internal Medicine Program Dr. Mark Fok Dr. Maria Ashley.
Fall Prevention subtitle.
Osteoporosis Osteoporosis is defined as a loss of bone mass or bone mineral density characterized by height reduction, fractures, back/neck pain, and stooped.
Chapter 9 Skeletal health. Chapter overview Introduction Biology of bone Osteoporosis: definition, prevalence and consequences Physical activity and bone.
Osteoporosis Let’s Work Together to Get Bone Healthy!
Osteoporosis Rajesh Kataria, D.O.. Osteoporosis “…is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of.
OSTEOPOROSIS Prof. Dr. Ülkü Akarırmak. Metabolic Bone Diseases Osteosclerosis Osteolysis Osteoporosis is the most common metabolic bone disease.
OSTEOPOROSIS 06/25/12 José L. González, PGY3. Definition  Reduction in bone strength  increase risk of fx  T-score: < -2.5 SDs  T-score: 30 yo, matched.
Beyond 5 years Francis F. Lopez, MD Medical Oncology.
Osteoporosis and Fractures Are Common, and Becoming More So
Selecting Candidates for Fracture Prevention Based on Risk Prediction Lubna Pal, MBBS, MRCOG, MS Assistant Professor Department of Obstetrics, Gynecology.
Genetics of Osteoporosis Dr. Tuan V. Nguyen Associate Professor, Senior Fellow Bone and Mineral Research Program Garvan Institute of Medical Research Sydney,
The epidemiology of fractures in Asia Dr. Lau EMC, MD President, Asian Pacific Osteoporosis Foundation Board member, International Osteoporosis Foundation.
Interpretation of Bone mineral density
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
Osteoporosis Dr. Faik Altıntaş Yeditepe Üniversitesi Tıp Fakültesi
Identification of individuals at high- risk of fracture Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium... 1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium...
The Different Modalities of Treatment of Osteoporosis Fracture Kuo-Ti Peng, M.D. Kuo-Ti Peng, M.D. Department of Orthopedics, Chang Gung Memorial Hospital.
Osteoporosis Management: Clinical scenario
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
By Siraya Kitiyodom ปัญหาที่เกี่ยวกับสุขภาพ ที่พบบ่อยในสตรีวัยทอง และวิธีการดูแล (Part II)
Falls Prevention 2007 The “Challenge” May 14, 2007 Dr. M. Sugai.
The Downward Spiral: Impact of Vertebral Body Compression Fractures
Osteoporosis Slide show
Fracture risk assessment
Garvan Institute of Medical Research Osteoporosis Treatment: Why, Who, What & When ? John A Eisman AO MB BS PhD FRACP Director, Bone and Mineral Research.
A Look at Osteoporosis Screening Guidelines Cynthia Phelan PGY
2010 Guidelines 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub.
Estrogen plus Progestin, BMD and Fractures: Women’s Health Initiative Jane A. Cauley University of Pittsburgh JAMA 2003; 290 (13) :
11 Quick Facts about Osteoporosis in Long-Term Care Homes Prevalence in LTC Who is at risk in LTC? Leading cause of fractures Reason for admission to LTC.
Design and Analysis of Clinical Study 10. Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.
Osteoporosis Dr Ramin Rafiei Alzahra Hospital Rheumatology Department.
Alimohammad Fatemi Assistant Professor of Rheumatology 1.
Prediction of Hip Fracture in Elderly Men and Women by Fall-related Factors ND Nguyen, C Pongchaiyakul, JR Center, JA Eisman, TV Nguyen Bone and Mineral.
COMMON LIFESTYLE DISEASES: OSTEOPOROSIS
Bones Part 4 DR. T Jim, Tyler and Matt.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
Prevention and Treatment of Osteoporosis
Welcome To Our Presentation
Chapter 47 Assessing Fracture Risk: Who Should Be Screened? © American Society for Bone and Mineral Research Contributed by John Schousboe, Brent Taylor,
Osteopenia and Osteoporosis Bradley K. Harrison, MD.
NICE, FRAX & NOGG VTS meeting Jonathan Day 7 th April 2010.
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
Osteoporosis Dr Janet Horner Leeds Teaching Hospitals NHS Trust.
Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.
OSTEOPOROSIS Dr Annie Cooper Consultant Rheumatologist Royal Hampshire County Hospital Winchester.
Osteoporosis Vinod Kurup, MD December 22nd, 2006 CC-BY-SA.
OSTEOPOROSIS Florence TREMOLLIERES, MD, PhD
dr. Muh. Ardi Munir, M.Kes, Sp.OT, M.H, FICS
Incidence rates for the three common osteoporotic fractures
Osteoporosis Definition
OSTEOPOROSIS. OSTEOPOROSIS Osteoporosis Osteoporosis affects both men and women. Its prevalence increases with age, and it is particularly common in.
Osteoporosis: Definition
Presentation transcript:

Osteoporosis: Measuring the Problem Dr. Tuan V. Nguyen Associate Professor Bone and Mineral Research Program Garvan Institute of Medical Research Sydney, Australia

Measuring osteoporotic fractures Magnitude of the problem Consequences Undertreated, underdiagnosed and what to do?

Increase in life expectancy WHO. Human Population: Fundamentals of Growth World Health, 2000.

The ageing of population Percent of population aged 65+ ABS and US Bureau of Census, 1996.

Osteoporosis – shift in definitions “Low bone mass, microarchitectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk” (Consensus Development Conference, 1991) “[…] compromised bone strength predisposing a person to an increased risk of fracture. Bone strength primarily reflects the integration of bone density and bone quality” (NIH Consensus Development Panel on Osteoporosis JAMA 285:785-95; 2001)

Shift in thinking Osteoporosis Fracture Bone Bone Bone Quality Mineral RISK FACTOR OUTCOME Osteoporosis Fracture Bone Quality Bone Mineral Density Bone Strength and Architecture Turnover rate Damage accumulation Degree of mineralization Properties of the collagen/mineral matrix

BMD and fracture T < 2.5 osteoporosis

14-year risk of fractures in WOMEN aged 60+ Osteoporosis 345 (27%) Non-osteoporosis 942 (73%) Fx = 137 (40%) No Fx = 208 (60%) Fx = 191 (20%) No Fx = 751 (80%) 42%

14-year risk of fractures in MEN aged 60+ Osteoporosis N = 90 (11%) Non-osteoporosis 731 (89%) Fx = 27 (30%) No Fx = 63 (70%) Fx = 91 (12%) No Fx = 640 (88%) 23%

Magnitude of the Problem

Incidence of all-limb fractures

Annual fracture incidence in Australia 1996-2051 Projected annual number of all-limb fractures in Australia aged 35+ (Sanders et al, MJA 1999)

Hip, vertebrae, and Colles fractures 2006 2051 Hip 20,700 60,000 Vertebrae 14,500 31,700 Colles 11,900 23,000 Humerus 7,500 16,300 Pelvis 4,100 9,800 Projected annual number of all-limb fractures in Australia aged 35+(Sanders et al, MJA 1999)

Lifetime risk of some diseases - women Any osteoporotic fracture Hip fracture Clinical vertebral fracture Cancer (any site)* Breast cancer* Lung/bronchus* Coronary heart diseases Diabetes Mellitus *, from birth (from the age of 50)

Lifetime risk of some diseases - men Any osteoporotic fracture Hip fracture Clinical vertebral fracture Cancer (any site)* Prostate cancer* Lung/bronchus* Coronary heart diseases Diabetes Mellitus *, from birth (from the age of 50)

Ten-year and lifetime risk of fractures 10-y risk Lifetime risk  with advancing age  with advancing age

Ten-year and lifetime risk of fractures Normal T-scores >-1.0 Osteopenia -2.5 < T-scores < -1.0 Osteoporosis T-scores < -2.5 Lifetime risk Age free-of-fracture (y) 10-y risk Age free-of-fracture (y)

Ten-year and lifetime risk of any fracture by BMD and age FNBMD 10-year risk Lifetime risk (T-score) Age free of fracture (y) 60 70 80 WOMEN > -1.0 3.6 13.2 13.0 23.4 22.6 -2.4 to -1.1 25.4 25.3 25.7 55.7 44.3 33.0  -2.5 35.8 40.1 42.3 72.2 64.9 54.8 MEN 9.7 7.6 15.1 25.1 18.4 9.3 10.3 35.3 23.7 30.0 29.8 29.2 56.4 44.8 36.5

Consequences of Osteoporotic Fractures

Survival probability in those with and without fracture Nguyen et al, 2005

Risk of death from hip fracture 50-year old women: Lifetime risk of mortality from: Hip Fracture: 2.8% Breast Cancer: 2.8% Endometrial Cancer: 0.7% Cummings et al. Arch Intern Med 1989; 149: 2445-8

Impact of hip fractures 25% die within 6 months (*) 60% have restricted mobility (*) 25% remain functionally more dependent Cardiac (8%) and pumonary complication (4%) Transient heart attacks Non-union and avancular necrosis (*) Data from the Dubbo Osteoporosis Epidemiology Study

Impact of vertebral fractures Symptomatic fx : Lifetime risk 1/4 women, 1/8 men Asymptomatic fx prevalence: 20-30% Back pain, functional limitation Rib-against-pelvis (RAP) syndrome Costoiliac impingement syndrome Decrease vital lung capacity Pongchaiyakul C et al, J Bone Miner Res 2005

Asymptomatic vertebral fracture increases risk of subsequent fractures 300 m+w 66 V # 234 No V # 29 Fx 37 no fx 54 Fx 180 no fx 44% 23% Pongchaiyakul C et al, J Bone Miner Res 2005

Asymptomatic vertebral fracture increases risk of death 300 m+w 66 V # 234 No V # 20 deaths 46 survived 25 deaths 209 survived 30% 11% Pongchaiyakul C et al, J Bone Miner Res 2005

Impact of wrist fracture More common in women in their 50s Post-traumatic arthritis Account for 39% of all physical therapy sessions Reduced daily living activies Melton LJ, J Bone Miner Res 2003

Utility loss associated with fracture

Under-treated & Under-diagnosis

What the experts say? “All women and men with a history of fragility fractures should be considered for treatment of osteoporosis to reduce their risk of future fracture.” (Seeman and Eisman, MJA 2004) “Initiate therapy to reduce fracture risk in postmenopausal women with BMD T-scores by DXA below -2 in the absence of risk factors and in women with T-scores below -1.5 if one or more risk factors are present.” (NOF 2003)

What the experts say? “Recommend BMD testing to postmenopausal women who have suffered a fragility fracture to confirm the diagnosis and determine disease severity.” (NOF 2003)

Levels of treatment in fractured women in primary care settings Eisman JA, et al, J Bone Miner Res 2004

Level of treatment in outpatients 157 low-trauma fx Prior fx: 76 No prior fx: 81 BMD: 35 (45%) Any Rx: 14 (18%) BMD: 18 (22%) Any Rx: 3 (10%) Bliuc D, et al, Osteoporosis Int 2004

Level of treatment – experience in the US 502 hospitalised hip-fracture patients: only 14% had BMD scans 13% received calcium and/or vitamin D 18% received HRT, calcitonin, or bisphosphonates. Harrington JT, et al. Arthritis Rheum 2002; 47: 651-654

Risk factor modifications for fracture Intervention Estimated change in fx risk Bisphosphonates, HRT, SERMs ~30-50% Quit smoking -38% Treat impaired vision -50% Stop sedatives -40% Hip protectors -50%?

Summary In individuals aged 60+: 25% women and 11% men are osteoporosis (eg low BMD) Lifetime risk of fracture (from the age of 50): 1/3 men and 1/2 women. With the presence of osteoporosis, lifetime risk increase to 1/2 men and 7/10 women

Summary Fracture, particularly hip fracture, is a serious public health problem in the elderly. Increase mortality risk, reduced quality of life, incurred health care costs Osteoporosis is both under-treated and under-diagnosed.